Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
First-Line Option Clear in Sequencing of HER2-Positive Breast Cancer Treatments
As more treatment options become available for metastatic HER2-positive breast cancer, some questions regarding the optimal sequencing of therapies remain…
Read More »
As more treatment options become available for metastatic HER2-positive breast cancer, some questions regarding the optimal sequencing of therapies remain…
Read More »
Anthracycline-Free Neoadjuvant Regimen Induces Response for HER2-Positive Breast Cancer Patients
Neoadjuvant chemotherapy is sometimes paired with anthracyclines, such as daunorubicin, doxorubicin, and epirubicin, to treat some types of breast cancer. Because of the success of this regimen for patients with breast cancer—with up to 65% of pathological complete responses (pCR)—this has become a standard of care…
Read More »
Neoadjuvant chemotherapy is sometimes paired with anthracyclines, such as daunorubicin, doxorubicin, and epirubicin, to treat some types of breast cancer. Because of the success of this regimen for patients with breast cancer—with up to 65% of pathological complete responses (pCR)—this has become a standard of care…
Read More »
The finding is a boost to cancer immunotherapy, a treatment strategy that unleashes theimmune system to seek out and destroy cancer. In a new ...
Fascinating New Cancer Clinical Trials at Gateway for Cancer Research 2015 Annual Meeting - PR Web (press release)
Again and again, your immune system misreads the chatter of these cells, and so allows them to multiply and grow. This is the exact problem scientists ...
Bristol shares fell as much as 2.7 percent and closed off 1 percent after reporting sales of Opdivo, a therapy that helps the immune system fight cancer, ...
... the immune system for cancer, is performing above analyst expectations. ... annual meeting of the American Association for Cancer Research earlier ...
It is considered a modified form of herpes virus, and is injected into tumors to kill cancercells and to strengthen the body's immune system against ...
Dr. Kim Lyerly, an internationally recognized expert in cancer therapy, told an ... The former director of the Duke Comprehensive Cancer Center, he was ... some are kept in control by the immune system—it could be decades before ...
They call Queensland the Sunshine State and for good reason, but too much time spent in the sun can lead to deadly melanoma, one of the most ...
... high-risk ones, will clear on their own by the body's immune system. However, some aggressive strains of the virus can cause cervical cancer.
In Custody
Expert tips for isolating and culturing cancer stem cells
SBRT Offers Short-Term Improvements Over Surgery in Early-Stage NSCLC
Though surgery is the standard treatment for early-stage non-small-cell lung cancer, a new study suggests that stereotactic body radiotherapy offers lower immediate mortality and toxicity…
Read More »
Though surgery is the standard treatment for early-stage non-small-cell lung cancer, a new study suggests that stereotactic body radiotherapy offers lower immediate mortality and toxicity…
Read More »
Annual Lung Cancer Screening Will Be Reimbursed for Select Patients
In this interview we discuss the recent CMS decision to cover low-dose CT screening for lung cancer in patients who fit specific criteria…
Read More »
In this interview we discuss the recent CMS decision to cover low-dose CT screening for lung cancer in patients who fit specific criteria…
Read More »
... significantly up-regulated in bladder cancers. However, the role of miR-221 in the progression of bladder cancer metastasis remains largely unknown.
(Reuters) - Amgen Inc's skin cancer immunotherapy showed enough efficacy in the treatment of melanoma to be given marketing approval, ...
Prostate cancers also fail to respond to a promising new type of immunotherapy drugs, called checkpoint inhibitors, which disable cancer cells' ...
"We have demonstrated in our preclinical models that adding GEN-1 to Avastin® can result in a powerful immunotherapy combination for cancer ...
As a result, these mutations offer an ideal target for cancer immunotherapies, if they give rise to tumor-specific antigens potentially targeted by mature ...
This can be achieved by immunotherapies — treatments specifically ... as well as many forms of cancer immunotherapy, depend on the activity of T ...
... clinical trial investigating the efficacy of the Company's patient-specific targeted cancer immunotherapycandidate NBS20 (USAN = eltrapuldencel-T) ...
Cancer Immunotherapy by Targeting Unique Cancer Mutations.
A prototype immunotherapy #cancer treatment shows promise in early tests, bringing forward the possibility that most human cancers may be eligible ...
MM-302 Shows Promise in Heavily Pretreated HER2-Positive Breast Cancer
MM-302 showed encouraging efficacy results and a manageable safety profile in heavily pretreated HER2-positive metastatic breast cancer patients.
MM-302 showed encouraging efficacy results and a manageable safety profile in heavily pretreated HER2-positive metastatic breast cancer patients.
HER2 Antigen-Specific T Cells Could Treat Sarcoma
T cells that express a HER2-specific chimeric antigen receptor showed promise as a treatment for HER-2 positive sarcoma in a small phase I/II trial.
T cells that express a HER2-specific chimeric antigen receptor showed promise as a treatment for HER-2 positive sarcoma in a small phase I/II trial.
Breast Cancer Survivors at Increased Risk for Thyroid Cancer
A recent study found that women diagnosed with breast cancer are at increased risk for developing thyroid cancer, prompting the authors to encourage regular screening for the disease in breast cancer survivors.
A recent study found that women diagnosed with breast cancer are at increased risk for developing thyroid cancer, prompting the authors to encourage regular screening for the disease in breast cancer survivors.
PALOMA-3 Trial of CDK 4/6 Inhibitor Palbociclib Stopped Early
Pfizer announced that the phase III trial of palbociclib was stopped early after meeting its primary endpoint of improved progression-free survival in women with HR-positive, HER2-negative metastatic breast cancer.
Pfizer announced that the phase III trial of palbociclib was stopped early after meeting its primary endpoint of improved progression-free survival in women with HR-positive, HER2-negative metastatic breast cancer.
Increased Risk of Second Malignancies With Radioactive Iodine Therapy for Thyroid Cancer
A new population-based study has found that patients with thyroid cancer who are treated with radioactive iodine therapy are at increased risk for developing salivary cancer as a second malignancy.
A new population-based study has found that patients with thyroid cancer who are treated with radioactive iodine therapy are at increased risk for developing salivary cancer as a second malignancy.
No Radiotherapy After Negative PET in Early-Stage Hodgkin Lymphoma
Patients with early-stage Hodgkin lymphoma who have a negative PET finding after 3 cycles of chemotherapy have a good prognosis without undergoing radiotherapy.
Patients with early-stage Hodgkin lymphoma who have a negative PET finding after 3 cycles of chemotherapy have a good prognosis without undergoing radiotherapy.
Rituximab More Cost-Effective Than Watch and Wait for Follicular Lymphoma
For patients with advanced follicular lymphoma, a treatment strategy of rituximab induction was the most cost-effective approach compared with watch and wait.
For patients with advanced follicular lymphoma, a treatment strategy of rituximab induction was the most cost-effective approach compared with watch and wait.
Exercise during chemo reduces nausea and fatigue
Although the benefits of exercise are clear after chemotherapy, a trial published in JCO recently confirmed that there are major benefits during chemotherapy, with little risk. What's more, it showed that amoung the 230 patients investigated those randomised to a high intensity supervised programme had particularly less nausea, vomiting and fatigue and more power and stamina to lead a normal life - full paper
Black obese men higher risk of prostate cancer than white obese men
A study in JAMA Oncology found that obesity in black men had a substantially higher risk of low- and high-grade prostate cancer, whereas obesity in white men only slightly increased their risk. More specifically, black men who were obese (BMI ≥ 35) had a 122% increased risk of low-grade and an 81% increased risk of high-grade prostate cancer - read more
Getting into shape at middle age profoundly protects men from cancer
Physically fit middle-aged men are less likely to develop lung and colon cancer in later life than their out-of-shape peers. Also, if they do develop cancer, they are more likely to beat it. Researchers looked at the notes of 14,000 men who had underwent treadmill tests at midlife. By 65 years or older those who performed well had a significantly lower risk of cancer by one-third lower. Interestingly the chance of getting prostate cancer was not reduced but the chance of surviving it was much higher - read more.
Chemotherapy induced nerve damaged helped by exercise
Chemotherapy can damage the nerves in the hands and feet causing troublesome burning, numbness, tingling or loss of reflexes. Men and women who have received oxaliplatin for colorectal cancer are particularly vulnerable but two recent studies from the USA and Denmark both show that those who perform 3 or more hours a week of moderate activity recover more quickly from this troublesome side effect - read more
More eggs less diabetes
Men who ate >5 eggs a week have been found to have a lower risk of developing type 2 diabetes than men who ate <1 20="" 2="" a="" analysis.="" and="" class="apple-converted-space" conducted="" disease="" factor="" finland="" followed="" for="" heart="" in="" ischaemic="" it="" kuopio="" nbsp="" of="" part="" participants="" published="" risk="" span="" study="" the="" this="" was="" week.="" years.=""> The American Journal of Clinical Nutrition - read more
Saunas are good for men!
A study from - yes you guest it - Finland - asked 2,315 men their sauna going habits via a questionnaire over 10 years.
Men who visited the sauna once a week had a 10% reduced risk of death within 10 years from cardiac arrest or heart disease but men who went 2-3 times per week had a 22% reduction and >4 times had a staggering 63% reduction in risk of death - read more
Quitting smoking improve outcomes after prostate cancer
Memorial Sloan Kettering Cancer Centre in New York evaluated 2,400 patients who underwent treatment for prostate cancer between 1988 and 2005. Although smoking has been previously shown to increase prostate cancer risk they found it is still important to give up because that those who continued to smoke during and after radiotherapy had double the prostate cancer specific death rate. Other studies have also shown smoking increased rectal damage. Clearly smokers after prostate should be strong counselled to quit. Read more | Tips to quit.
Vitamin D directly effects prostate cancer cells
A study has provided further insights into the potential anti-cancer properties of Vit-D. Researchers randomised 37 to receive either 4000 u Vit-D or placebo for 60 days pre prostatectomy. At surgery there was a significant improvement in features of cancer activity in the vit-D group. They did not measure levels before so we don't know if this just benefited those who were deficient pre trial - see trial video
Unregulated copies of Pomi-T are hitting UK websites
The UK manufacturers have reported to us that batches of unregulated Pomi-T have been found on some UK websites. This is concerning because the original pomi-T underwent a very strict quality assurance programme required for the original UK trial.This included mass spectrometry, authenticity and contamination assays. As the UK manufacturers agreed to continue this QA process the best way to be sure is to get it from them directly >>>
Report highlights the extent of health problems caused by xenoestrogens
Exposure to xenoestrogens is leading to an increased risk of health problems, including cancer, costing > $175 billion / year in Europe. These chemicals that can mimic or block oestrogen are commonly found in thousands of products including plastics, pesticides, furniture, and cosmetics - read report
Sugar lowering drug helps men with prostate cancer
A meta-analysis of 8 retrospective cohort studies found that the drug metformin, given to mildly diabetic men, was associated with a an 18% decreased risk of PSA relapse in men treated for prostate cancer. For those treated with radiotherapy this was as high as 50%. More research is ongoing but in the mean time diabetics not on metformin should discuss a change with their physicians read more
Online micro-nutritional testing - optimise your nutritional status
Most top athletes measure their body's essential micro-nutrients to ensure they have the correct nutritional balance for optimal performance. These tests are now available for everyone especially those concerned about or who have survived cancer.
An online micro-nutrient service has been developed by cancernet which measures over 50 of the bodies essential micro-nutrients and anti-cancer enzymes.
The results of the detailed blood test are issued with a bespoke advice programme which empowers the recipient to a diet and lifestyle which corrects deficiencies and lowers excesses to restore optimal nutritional status - read more about micro-nutrient testing
Lifestyle and Cancer - the facts
This latest edition of Lifestyle and Cancer dispells the myths by providing clear evidence based advice, to help readers cope with side effects, speed up recovey and reduce the risk of relapse after cancer Order online
A new scheme is also now available to advocacy groups and hospitals - The publishers are able to supply at cost price to groups who can sell on to members at a discount Contact us about joinng this scheme
Read foreword by Paula Radcliffe
Read free sample chapter - Avoiding carcinogens
Measure and plot your PSA doubling time (PSAdt)
| This application is useful for doctors and patients alike as it quickly and accurately calculates the rate of rise of two or more PSA blood measurements over time - more important measurement than an isolated single level. This is particularly useful for men with prostate cancer managed with Active Surveillance or experiencing a PSA relapse after previous treatments. The PSA doubling time over any period of time is displayed in an easily readable graph so one can accurately see if it is shortening (bad) or lengthening (good) in response to lifestyle changes or oral supplements such as Pomi-T. The graph can be updated with each blood test and the results emailed to your home computer or doctor - read more |
Tambahkan Komentar